4D Molecular Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | — | -416.3% | -416.5% |
| FY2021 | — | -395.5% | -395.4% |
| FY2022 | — | -3,516.5% | -3,435.4% |
| FY2023 | — | -544.6% | -486.6% |
| FY2024 | — | -507,678.4% | -434,778.4% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | — | -416.3% | -416.5% |
| FY2021 | — | -395.5% | -395.4% |
| FY2022 | — | -3,516.5% | -3,435.4% |
| FY2023 | — | -544.6% | -486.6% |
| FY2024 | — | -507,678.4% | -434,778.4% |